Kushenol I combats ulcerative colitis via intestinal barrier preservation and gut microbiota optimization

Figure 4 Impact of kushenol I on the clinical symptoms and colonic histopathology in mice with dextran sulfate sodium-induced ulcerative colitis. A: Changes in body weight during the experiment; B: Disease activity index scores of mice; C: Colon length; D: Representative photographs of mouse colons. Values are presented as the mean ± SD (n = 6). ^bP < 0.01. ^cP < 0.001. P compared with the model group.